Publications by authors named "Kelly Dooley"

Claim this Profile
F
Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial.
Anushka Naidoo, Kogieleum Naidoo, Marothi P Letsoalo, Roeland E Wasmann, Gillian Dorse, Kelly E Dooley

Lancet HIV· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis.
Veronique de Jager, Laurynas Mockeliunas, Huifang You, Ulrika S H Simonsson, Tarryn Collings, Kelly E Dooley

Clin Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of isoniazid in pediatric tuberculosis: an individual participant data meta-analysis.
Agathe Béranger, Belén P Solans, Ryo Miyakawa, Helen McIlleron, Joel Tarning, Kelly Dooley

Eur Respir J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and Rifampicin.
Emmanuella Chinonso Osuala, Ivan Nicholas Nkuhairwe, Marothi Peter Letsoalo, Kogieleum Naidoo, Rubeshan Perumal, Kelly E Dooley

Clin Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design.
Ekaterina V Kurbatova, Kelly E Dooley, Wendy Carr, Jason E Stout, Eric L Nuermberger

Contemp Clin Trials· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensified Treatment of Tuberculous Meningitis in Adults: A Systematic Review and Meta-analysis.
Andrea Llamas-Lopez, James A Seddon, Felicia C Chow, Caryn M Upton, Sanjay K Jain, Kelly Dooley

Open Forum Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REVOLUTIONIZING TUBERCULOSIS REGIMEN DEVELOPMENT.
Kelly E Dooley, Radojka Savic

Trans Am Clin Climatol Assoc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis.
Linda J Harrison, Gustavo E Velásquez, Russell R Kempker, Marjorie Z Imperial, Eric Nuermberger, Kelly E Dooley

Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical practice guideline for tuberculous meningitis.
Joseph Donovan, Fiona V Cresswell, Elizabeth W Tucker, Angharad G Davis, Ursula K Rohlwink, Kelly E Dooley

Lancet Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence Generation for a Host-Response Biosignature of Respiratory Disease.
Kelly E Dooley, Michael Morimoto, Piotr Kaszuba, Margaret Krasne, Gigi Liu

Viruses· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis.
Nia Covington, Anne F Luetkemeyer, Marjorie Z Imperial, Rodney Dawson, Yoninah Cramer, Kelly E Dooley

Pharmacogenet Genomics· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial.
Ethel D Weld, Trevor Beattie, Jayajothi Moodley, Manasa Mapendere, Isadora Salles, Kelly E Dooley

Lancet HIV· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis disease among people with HIV: therapeutic advances.
Vidya Mave, Mandar Paradkar, Francesca Conradie, Amita Gupta, Anchalee Avihingsanon, Kelly E Dooley

Lancet HIV· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, Gustavo E Velásquez, Payam Nahid, Kelly E Dooley

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a time-varying correction factor for QT interval assessment in drug-resistant tuberculosis patients.
Thanakorn Vongjarudech, Anne-Gaëlle Dosne, Bart Remmerie, Kelly E Dooley, James C M Brust

Int J Antimicrob Agents· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort study.
Anushka Naidoo, Hylke Waalewijn, Kogieleum Naidoo, Marothi Letsoalo, Gabriela Cromhout, Kelly E Dooley

Lancet HIV· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous analysis of isoniazid and pyrazinamide in cerebrospinal fluid.
Sydwell Poulo Maputla, Anton Joubert, Sandra Castel, Marthinus van der Merwe, Edda Zangenberg, Kelly E Dooley

J Pharm Biomed Anal· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.
Ekaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, Patrick P J Phillips, Nigel A Scott, Kelly E Dooley

Emerg Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACTG A5409 (RAD-TB): Study Protocol for a Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis.
Linda Harrison, Gustavo E Velasquez, Russell R Kempker, Marjorie Z Imperial, Eric Nuermberger, Kelly E Dooley

Res Sq· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review.
Violet Chihota, Makaita Gombe, Amita Gupta, Nicole Salazar-Austin, Tess Ryckman, Kelly E Dooley

Drugs· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing the chemotherapy of tuberculous meningitis: a consensus view.
Sean Wasserman, Joseph Donovan, Evelyne Kestelyn, James A Watson, Robert E Aarnoutse, Kelly E Dooley

Lancet Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical predictors of 3-month isoniazid rifapentine (3HP)-related adverse drug reactions (ADR) during tuberculosis preventive therapy (PAnDoRA-3HP study): an observational study protocol.
Christine Sekaggya-Wiltshire, Irene Mbabazi, Ruth Mirembe Nabisere, Lucy Alinaitwe, Brian Otaalo, Kelly E Dooley

BMJ Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, Gustavo E Velásquez, Payam Nahid, Kelly E Dooley

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis.
Lennert Verboven, Steven Callens, John Black, Gary Maartens, Kelly E Dooley

PLoS One· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and diagnostic features of central nervous system tuberculosis in Indian children - a descriptive study.
Bella Devaleenal Daniel, Elilarasi Selladurai, Sarath Balaji, Arunagirinathan Venkatesan, Mythily Venkatesan, Kelly E Dooley

Ther Adv Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis